Showing results (41-50 of 17,194) with videos related to
Sort By:
Pageof 1,720
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1981
Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartmentB C Chu, S B HowellProceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitroJ A Streifel, S B HowellBritish Journal of Cancer|June 1, 1993
Cellular accumulation of the anticancer agent cisplatin: a reviewD P Gately, S B HowellJournal of the National Cancer Institute|May 1, 1991
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamoleS Isonishi, S Kirmani, S Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Extended CSF cytarabine exposure following intrathecal administration of DTC 101S Kim, E Chatelut, J C Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
The role of DNA mismatch repair in drug resistanceD Fink, S Aebi, S B HowellActa Medica Austriaca|January 1, 1989
Novel approaches to intraperitoneal drug deliveryS B Howell, S Kirmani, R GoelEuropean Journal of Cancer & Clinical Oncology|September 1, 1985
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protectionM Markman, S Cleary, S B HowellBlood|March 1, 1980
Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemiaS B Howell, R Taetle, J MendelsohnJournal of Cellular Physiology|June 1, 1994
Cisplatin sensitivity correlates with its ability to cause cell cycle arrest via a wee1 kinase-dependent pathway in Schizosaccharomyces pombeF Thiebaut, R Enns, S B HowellPageof 1,720